NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma

Clinical trial NCT07680699 · RECRUITING

Trial details

NCT number: NCT07680699
Sponsor: AC Camargo Cancer Center
Status: RECRUITING
Study type: OBSERVATIONAL

Cutaneous Melanoma

Start date: 2025-04-23
Primary completion: 2027-05-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.